STEMCELL Technologies
Roy Musil has an extensive career in quality management and regulatory compliance within the biopharmaceutical industry. Currently serving as the Executive Advisor to the CEO and Senior Vice President of Quality at STEMCELL Technologies since April 2017, Musil previously held several senior roles, including Senior Director of Quality at Juno Therapeutics, Inc., and Vice President of Quality at CMC Biologics. Additional experience includes leadership positions at Mentor Biologics, Amgen, Althea Technologies, SmithKline Beecham, The Immune Response Corporation, IBEX, and the NRC Biotechnology Research Institute. Musil holds a Master of Science degree in Biochemistry and a Bachelor of Science degree in Biochemistry, both from Concordia University.
This person is not in any teams
This person is not in any offices